Yes, obesity is officially classified as a disease. The American Medical Association voted to recognize it as a disease state in June 2013, and the World Health Organization’s current International Classification of Diseases (ICD-11) defines it as a chronic, complex disease characterized by excessive body fat that impairs health. The American Association of Clinical Endocrinologists had reached the same conclusion a year earlier, in 2012. This classification wasn’t arbitrary. It was based on the same criteria used to define other chronic diseases: identifiable signs, underlying biological dysfunction, and a clear link to serious complications and increased mortality.
Why Medical Organizations Call It a Disease
To qualify as a disease in a medical sense, a condition generally needs to meet three criteria: it impairs the normal functioning of the body, it produces characteristic signs or symptoms, and it causes measurable harm. The AMA’s Council on Science and Public Health evaluated obesity against all three.
On the first count, obesity involves a range of biological dysfunctions. These include disrupted appetite regulation, abnormal energy balance, insulin resistance, elevated levels of the hormone leptin, chronic low-grade inflammation, abnormal blood pressure regulation, and changes in liver function. These aren’t consequences of eating too much. They are measurable physiological breakdowns in how the body manages energy and fat storage.
On the second count, excess body fat produces both structural and metabolic effects. Joint pain, reduced mobility, and sleep apnea fall on the structural side. Progression toward type 2 diabetes and cardiovascular disease fall on the metabolic side. On the third count, obesity is directly associated with increased mortality. Losing weight improves outcomes across the board: better blood sugar control, lower cardiovascular risk, reduced rates of certain cancers, and relief from osteoarthritis and sleep apnea symptoms.
The Biology Behind the Classification
One of the strongest arguments for treating obesity as a disease rather than a lifestyle choice comes from how the body regulates hunger and energy use. A hormone called leptin plays a central role. Leptin is produced by fat cells and signals the brain to reduce appetite when energy stores are sufficient. In a well-functioning system, more body fat means more leptin, which means less hunger. The system self-corrects.
In obesity, this feedback loop breaks down. Leptin levels are often elevated, sometimes dramatically so, but the brain stops responding to the signal. This is called leptin resistance. It happens through several mechanisms: reduced transport of leptin across the blood-brain barrier, impaired receptor function in the hypothalamus (the brain region that governs appetite), and disrupted intracellular signaling downstream of the leptin receptor. The practical result is that the brain behaves as though the body is underfed, even when fat stores are abundant. Hunger persists, energy expenditure drops, and the body actively defends a higher weight.
This isn’t a matter of willpower. The same brain circuits that regulate appetite also influence the production of appetite-suppressing and appetite-stimulating molecules. Leptin normally stimulates the production of compounds that suppress hunger and inhibits the ones that increase it. When leptin resistance develops, both sides of that equation shift toward weight gain. The biology is working against the person, not with them.
Diagnosis Goes Beyond BMI
BMI has long been the default screening tool for obesity, but the medical field increasingly recognizes its limitations. A 2025 framework integrating recommendations from the Lancet Commission on Obesity now defines “clinical obesity” as a condition where confirmed excess body fat causes measurable dysfunction in at least one of 11 body systems or one functional domain.
Body fat distribution matters as much as total body fat. Waist circumference above 102 cm in men or 88 cm in women, a waist-to-hip ratio above 0.9 in men or 0.85 in women, and a waist-to-height ratio above 0.5 all indicate higher-risk fat distribution, regardless of what BMI says.
The functional criteria are wide-ranging. They include cardiovascular markers like elevated blood pressure and heart failure, metabolic markers like high blood sugar and abnormal cholesterol, kidney dysfunction, liver disease, reproductive problems (infertility, polycystic ovary syndrome, erectile dysfunction), and neurological effects like vision loss from raised intracranial pressure. Physical limitations matter too. If excess weight means you can’t manage a flight of stairs, or chronic joint pain limits your daily activities, that counts as disease-level impairment.
This staging approach means two people with the same BMI can receive very different diagnoses. Someone with a BMI of 33 and no organ dysfunction is in a different clinical category than someone with a BMI of 33 who has prediabetes, knee osteoarthritis, and sleep apnea. The disease label applies when the excess fat is actively causing harm.
What the Disease Label Changed
The AMA’s 2013 decision had several practical goals. First, it was expected to improve insurance coverage and reimbursement for obesity treatment. Before the classification, many insurers treated weight management as elective or cosmetic rather than medically necessary. Recognizing obesity as a disease opened the door for coverage of medical interventions, behavioral programs, and surgical options as treatments for a legitimate health condition rather than lifestyle upgrades.
Second, the classification was intended to drive research funding. When a condition is recognized as a disease, it attracts more institutional support for studying its causes, prevention, and treatment. Third, and perhaps most significantly for patients, the designation was meant to shift how people think about obesity. Calling it a disease communicates that it has biological drivers, that it is not simply a failure of self-control, and that it deserves the same clinical seriousness as hypertension or diabetes.
The Case Against the Disease Label
Not everyone agrees with the classification. The AMA’s own Council on Science and Public Health actually raised concerns before the vote, noting that BMI, the most commonly used diagnostic tool, is a flawed measure that doesn’t distinguish between fat and muscle or account for where fat is stored. Labeling millions of people as “diseased” based on a single number struck some physicians as overreach.
A broader concern is that medicalizing obesity could undermine personal agency. If obesity is a disease that happens to you, some argue, it may reduce motivation to make behavioral changes that genuinely help. Others worry about the pharmaceutical implications: a disease classification creates a market for drug treatments, and there’s a financial incentive for the healthcare industry to frame the condition in terms that favor medical intervention over public health measures like improving food environments or urban design.
There’s also a philosophical question about where to draw the line between disease and risk factor. High blood pressure is a disease, but it’s also a risk factor for stroke. Obesity similarly increases risk for dozens of conditions. Whether excess body fat is itself the disease or merely a precursor to disease remains a point of genuine debate in medicine.
Stigma Cuts Both Ways
One argument for the disease label is that it reduces stigma by shifting blame away from the individual. In practice, the picture is more complicated. Research shows that healthcare providers, even well-intentioned ones, hold unconscious biases about patients with larger bodies. Common assumptions include that these patients are less motivated, noncompliant, and lacking in willpower. When patients experience this kind of bias in medical settings, they are more likely to avoid seeking care in the future, which worsens health outcomes.
The disease label can also create a different kind of stigma. When BMI becomes the primary lens through which a provider views a patient, the patient’s other health concerns may be dismissed or attributed to weight. People internalize these messages, and the result is often self-blame, shame, and disordered eating patterns, all of which make weight management harder, not easier. The psychological toll is real: weight stigma is associated with heightened stress, anxiety, depression, and lower self-esteem, independent of the physical effects of carrying excess weight.
The most useful framing may be the one emerging in current clinical guidelines, which focus less on the label and more on whether excess body fat is causing specific, measurable harm in a given person. That approach treats obesity as a disease when it functions as one, without reducing every person above a certain BMI to a diagnosis.